CPRX vs. CL
Compare and contrast key facts about Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CPRX or CL.
Correlation
The correlation between CPRX and CL is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
CPRX vs. CL - Performance Comparison
Loading data...
Key characteristics
CPRX:
1.19
CL:
-0.07
CPRX:
1.95
CL:
0.04
CPRX:
1.22
CL:
1.01
CPRX:
1.65
CL:
-0.07
CPRX:
6.46
CL:
-0.12
CPRX:
7.40%
CL:
11.70%
CPRX:
41.35%
CL:
20.48%
CPRX:
-94.25%
CL:
-58.90%
CPRX:
-5.32%
CL:
-14.75%
Fundamentals
CPRX:
$2.97B
CL:
$73.93B
CPRX:
$1.57
CL:
$3.53
CPRX:
15.52
CL:
25.84
CPRX:
0.00
CL:
1.94
CPRX:
5.56
CL:
3.71
CPRX:
3.65
CL:
200.10
CPRX:
$534.65M
CL:
$19.95B
CPRX:
$441.72M
CL:
$12.11B
CPRX:
$250.28M
CL:
$4.82B
Returns By Period
In the year-to-date period, CPRX achieves a 16.77% return, which is significantly higher than CL's 1.49% return. Over the past 10 years, CPRX has outperformed CL with an annualized return of 19.87%, while CL has yielded a comparatively lower 5.29% annualized return.
CPRX
16.77%
8.21%
18.30%
47.79%
40.03%
19.87%
CL
1.49%
-4.47%
-1.39%
-0.99%
7.88%
5.29%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CPRX vs. CL — Risk-Adjusted Performance Rank
CPRX
CL
CPRX vs. CL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Colgate-Palmolive Company (CL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
CPRX vs. CL - Dividend Comparison
CPRX has not paid dividends to shareholders, while CL's dividend yield for the trailing twelve months is around 2.21%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CL Colgate-Palmolive Company | 2.21% | 2.18% | 2.40% | 2.36% | 2.10% | 2.05% | 2.48% | 2.79% | 2.11% | 2.37% | 2.25% | 2.05% |
Drawdowns
CPRX vs. CL - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, which is greater than CL's maximum drawdown of -58.90%. Use the drawdown chart below to compare losses from any high point for CPRX and CL. For additional features, visit the drawdowns tool.
Loading data...
Volatility
CPRX vs. CL - Volatility Comparison
Catalyst Pharmaceuticals, Inc. (CPRX) has a higher volatility of 10.00% compared to Colgate-Palmolive Company (CL) at 6.83%. This indicates that CPRX's price experiences larger fluctuations and is considered to be riskier than CL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
CPRX vs. CL - Financials Comparison
This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Colgate-Palmolive Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CPRX vs. CL - Profitability Comparison
CPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported a gross profit of 123.51M and revenue of 141.42M. Therefore, the gross margin over that period was 87.3%.
CL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Colgate-Palmolive Company reported a gross profit of 2.99B and revenue of 4.91B. Therefore, the gross margin over that period was 60.8%.
CPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported an operating income of 63.37M and revenue of 141.42M, resulting in an operating margin of 44.8%.
CL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Colgate-Palmolive Company reported an operating income of 1.08B and revenue of 4.91B, resulting in an operating margin of 21.9%.
CPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Catalyst Pharmaceuticals, Inc. reported a net income of 56.74M and revenue of 141.42M, resulting in a net margin of 40.1%.
CL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Colgate-Palmolive Company reported a net income of 690.00M and revenue of 4.91B, resulting in a net margin of 14.1%.